HE4 in ovarian cancer: from discovery to clinical application

M Montagnana, E Danese, S Giudici… - Advances in clinical …, 2011 - books.google.com
Despite the relatively low prevalence, ovarian cancer is the fifth leading cause of death from
cancer among women. As such, an early diagnosis for establishing a timely surgical and/or …

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases

JM Escudero, JM Auge, X Filella, A Torne… - Clinical …, 2011 - academic.oup.com
BACKGROUND Human epididymis protein 4 (HE4), a precursor of human epididymis
protein, has been proposed as a tumor marker for ovarian cancer. We evaluated HE4 in …

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

R Molina, JM Escudero, JM Augé, X Filella, L Foj… - Tumor Biology, 2011 - Springer
The aim of this study is to evaluate a new tumour marker, HE4, in comparison with CA 125
and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients …

Benign causes of increased serum CA-125 concentration

A Sevinc, M Adli, ME Kalender, C Camci - The lancet oncology, 2007 - thelancet.com
We read with interest the excellent Review by Goonewardene and colleagues1 recently
published in The Lancet Oncology, which focused on the management of patients with …

Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid

HM Turk, H Pekdemir, S Buyukberber, A Sevinc… - Tumor biology, 2003 - karger.com
Malignant and nonmalignant serosal fluids have been found to be associated with high
serum levels of CA 125, suggesting that the presence of fluid in the serosal cavities may …

[HTML][HTML] Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma

GI Hwang, CH Yoo, BH Sohn, JH Shin… - … : official journal of …, 2004 - synapse.koreamed.org
Purpose Peritoneal metastasis is a crucial factor for the prognosis in gastric cancer, but its
diagnosis is difficult before laparotomy. This study analyzed the usefulness of diagnostic …

[HTML][HTML] Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis

SJ Kang, JW Kim, JH Baek, SH Kim… - World journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To investigate the usefulness of tumor markers and adenosine deaminase in
differentiating between tuberculous peritonitis (TBP) and peritoneal carcinomatosis (PC) …

Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer

M Muller, R Hoogendoorn, RJG Moritz… - Tumor …, 2021 - content.iospress.com
BACKGROUND: The widespread introduction of immunotherapy in patients with advanced
non-small cell lung cancer (NSCLC) has led to durable responses but still many patients fail …

Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study

K Bosse, K Rhiem, B Wappenschmidt, M Hellmich… - Gynecologic …, 2006 - Elsevier
OBJECTIVE.: This study evaluates the accuracy of transvaginal ultrasound (TVUS) in
combination with CA125 to detect ovarian cancer in women at hereditary risk for ovarian …

[HTML][HTML] Laparoscopic surgical management and clinical characteristics of ovarian fibromas

CE Son, JS Choi, JH Lee, SW Jeon… - JSLS: Journal of the …, 2011 - ncbi.nlm.nih.gov
Objective: This study aims to analyze the clinical characteristics and diagnostic features of
ovarian fibromas and to evaluate the efficacy and safety of laparoscopic surgery for ovarian …